Resumen
Our proprietary preparation obtained by extraction of Chlorella pyrenoidosa cells, ONC-107 (Respondin™), was recently found to selectively boost antibody response to the influenza vaccine in a human clinical trial. Respondin™ is a potent stimulator of mouse B cell proliferation and an activator of macrophages. Bioactivity-guided resolution concluded that Respondin™ is composed of a mixture of immunostimulatory principles of different chemical nature. A combination of size exclusion, anion exchange and hydrophobic interaction chromatography revealed that the bulk of the immunostimulatory activity resides in polysaccharide/protein complexes with molecular masses larger than 100 kDa that are composed primarily of galactose, rhamnose and arabinose.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 57-64 |
Número de páginas | 8 |
Publicación | Phytomedicine |
Volumen | 14 |
N.º | 1 |
DOI | |
Estado | Published - ene. 10 2007 |
Nota bibliográfica
Funding Information:This study was supported in part by the IRAP program of the National Research Council of Canada.
ASJC Scopus Subject Areas
- Molecular Medicine
- Pharmacology
- Pharmaceutical Science
- Drug Discovery
- Complementary and alternative medicine
PubMed: MeSH publication types
- Journal Article
- Research Support, Non-U.S. Gov't